Slide Deck - Discussion of "Masking Policies at National Cancer Institute–Designated Cancer Centers During Winter 2023 to 2024 COVID-19 Surge"

2/

3/

4/

5/ "Scenario planning: a framework for mitigating uncertainty in implementing strategic behavioral medicine initiatives during the COVID-19 pandemic"

6/ Cancer is a COVID-19 risk factor.

7/

8/

9/

10/ NCI-designated cancer centers comprise approximately 4% of U.S. cancer centers. At the NCI-designated cancer centers, about 85% of those in the top quintile had universal masking policies in winter 2023-24, as did about 34% of other NCI-designated centers.

11/ 42% of NCI-designated cancer centers had universal masking policies during the winter 2023-24 surge, but numbers were significantly higher in the northeast and at centers with higher quality indicators.

12/ The Midwest and South lagged on masks in healthcare, despite higher overall transmission during the winter 2023-24 surge.

13/ Apply the "Diffusion of Innovation" framework to organizational changes surrounding airborne illness transmission

14/

15/ COVI-CAN The Covid Defense Kit for patients undergoing cancer treatment and their families.

16/

17/

18/ "Airborne transmission of respiratory viruses"

19/ "Back to the future: Redefining 'universal precautions' to include masking for all patient encounters"

20/ "Masks and respirators for prevention of respiratory infections: a state of the science review"

21/

22/

23/

24/

25/

yes